eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Biogen Idec Ltd

Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, UK
Telephone: +44 (0)1628 501 000
Fax: +44 (0)1628 501 010
Medical Information Direct Line: 0800 008 7401
Medical Information e-mail: biogenidec@professionalinformation.co.uk
Medical Information Fax: +44(0)1748 828801
Out of Hours Telephone: 0800 008 7401

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 04/11/2011
PIL AVONEX 30 micrograms powder and solvent for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Removal/change of distributor
  • Change to date of revision
  • Change to side-effects
  • Change to name of manufacturer
Updated on 22/06/2011 and displayed until 04/11/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/06/2011 and displayed until 22/06/2011
Reasons for adding or updating:
  • Removal/change of distributor
  • Change to date of revision
Updated on 07/01/2009 and displayed until 20/06/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Correction of spelling/typing errors
Updated on 07/08/2008 and displayed until 07/01/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 25/03/2008 and displayed until 07/08/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/12/2007 and displayed until 25/03/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 08/03/2007 and displayed until 11/12/2007
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 02/02/2007 and displayed until 08/03/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change of contra-indications
Updated on 24/07/2006 and displayed until 02/02/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   interferon beta-1a